OAKLAND, Calif., Jan. 20, 2026 (GLOBE NEWSWIRE) — LaunchDarkly, the comprehensive feature management platform, today announced the appointment of Cameron Etezadi as Chief Technology Officer and Robert O'Donovan as Chief Financial Officer, along with the return of Jonathan Nolen as SVP of Product. These additions to the executive team come as the company is nearing […]
(NasdaqGM:CCLD),(NasdaqGM:CCLDP),(NasdaqGM:CCLDO), SOMERSET, N.J., Jan. 20, 2026 (GLOBE NEWSWIRE) — CareCloud, Inc. (“CareCloud” or the “Company”) (Nasdaq: CCLD, CCLDO), a leader in healthcare technology and generative AI solutions for medical practices and health systems nationwide, announced today that its Board of Directors (the “Board”) has declared monthly cash dividends for its 8.75% Series A Cumulative Redeemable
(NYSE MKT: VTAK), FORT MILL, S.C., Jan. 20, 2026 (GLOBE NEWSWIRE) — Catheter Precision, Inc. (VTAK – NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market today announced receipt of a VIVO purchase order from University Clinical Center Ljubljana, a leading hospital in Slovenia. This expands
Phoenix, AZ, Jan. 20, 2026 (GLOBE NEWSWIRE) — Cordia, a leading provider of energy solutions, announced today that it has signed a 20-year agreement to provide chilled water service to the new Arizona State University (ASU) Health headquarters at the Phoenix Bioscience Core (PBC). The building will be cooled from Cordia's Plant 4, a new
Finalists advancing Northern Virginia’s leadership in AI infrastructure, economic impact, and digital innovation The Northern Virginia Technology Council (NVTC), the region’s leading technology trade association, today announced the finalists for the seventh annual NVTC Data Center Awards, recognizing the companies and leaders shaping the future of digital infrastructure and the global AI-driven economy. Northern Virginia
(NYSE:NSRX), Interim results indicate NS002 demonstrated significantly faster absorption and higher peak epinephrine levels compared to EpiPen(R) 91% of study participants achieved the 100 pg/ml plasma threshold at 5 minutes with NS002 compared to 67% with EpiPen(R) NS002 was well-tolerated with no serious adverse events reported, and a pharmacodynamic response comparable to EpiPen(R) Full Phase
Gamgertamig previously received Orphan Drug Designation (ODD) for development in immune thrombocytopenia and autoimmune hemolytic anemia Ouro Medicines, a clinical stage biotechnology company developing immune reset therapeutics for people living with chronic, immune-mediated diseases, today announced that gamgertamig (OM336), the company’s BCMAxCD3 T cell engager antibody investigational candidate, has been granted U.S. Food and Drug
Omni-channel rollout empowers consumers to cut through wellness noise and make more confident, science-backed decisions Thorne, the leader in science-backed health and wellness solutions, today unveiled its nationwide, omni-channel Now I Know campaign, designed to help consumers navigate modern wellness with confidence, clarity, and evidence they can trust. Today’s wellness landscape is marked by an
Lazard, Inc. (NYSE: LAZ) today announced Peter R. Orszag, CEO and Chairman, is scheduled to participate in a fireside discussion at the Bank of America Financial Services Conference on Tuesday, February 10, at 9:40 a.m. E.T. A live audio webcast will be available via the Lazard Investor Relations website at www.lazard.com. A replay will be
Payoneer (NASDAQ: PAYO), the global financial technology company powering business growth across borders, today announced it has acquired Boundless, an Ireland-based Employer of Record (EOR) platform that helps companies seamlessly and compliantly employ people around the world. This acquisition marks another step in Payoneer’s strategy to deliver a comprehensive financial stack for small-and medium-sized businesses